Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

Eli Lilly is expanding its private financing ambitions, partnering with venture capital firm Andreessen Horowitz on a new ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

As Meta moves away from fact-checking, HEC Paris professor David Restrepo Amariles warns of fake news' risks for businesses, ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...

X will start adding parody labels to accounts and posts as the company tries to add some form of transparency to the platform ...

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

AbbVie will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Management will participate in a fireside chat at 10:15 a.m. Central time. A live audio webcast ...